Harmony Biosciences

HRMYNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.452 B

$42.10 +0.19%

Close of 21 Sept 2026

Revenue

$868.5M

#1602 by revenue

Earnings

$158.7M

#1105 by earnings

Shares outstanding

58,236,393

Latest filing cover page

P/E ratio

15.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#89Supernus PharmaceuticalsSUPN$2.49B
#90Vera TherapeuticsVERA$2.47B
#91Harmony BiosciencesHRMY$2.45B
#92Viridian TherapeuticsVRDN$2.44B
#93SELLAS Life Sciences GroupSLS$2.30B

What if Harmony Biosciences were worth as much as…

Open the what-if tool →

Gold $30.3T

$519,847.69

Per share 12,348× higher

Bitcoin $1.72T

$29,531.43

Per share 701× higher

Nvidia $5.48T

$94,096.80

Per share 2,235× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Harmony Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.